Integrated genomic analysis of small intestinal neuroendocrine tumors provides further insights into molecular subgroups and identifies putative driver genes
Backman, S.; Barazeghi, E.; Norlen, O.; Hellman, P.; Stalberg, P.
Show abstract
Small intestinal neuroendocrine tumors (SI-NETs) are the most common tumor of the small intestine. Despite typically being metastatic at the time of diagnosis, the tumors are usually indolent and associated with a relatively long survival. Nevertheless, some patients fare worse and succumb to the disease soon after diagnosis despite similar stage and grade. To date, molecular prognostic markers are lacking, and our understanding of the disease biology is incomplete. Only CDKN1B is recurrently mutated in a subset of cases. Copy number alterations, including loss of chromosome 18, are common. However, the oncogenic mediators of these alterations remain unknown. The aim of this study was to identify molecular derangements in SI-NETs and identify potential prognostic markers. Forty tumor samples (including ten paired metastatic and primary tumors) from thirty patients with unusually long or unusually short survival after diagnosis were included for whole genome sequencing. Twenty of the samples were also included for RNA Sequencing. We validate known gene mutations and copy number alterations, as well as previously described molecular subgroups. We identify potential prognostic markers based on gene expression. Finally, we identify genes whose expression is affected by the most common copy number alterations in these tumors.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Extensive patient-to-patient single nuclei transcriptome heterogeneity in pheochromocytomas and paragangliomas 94%
- Analysis of Mutational Profile of Hypopharyngeal and Laryngeal Head and Neck Cancers Identifies KMT2C as a Potential Tumor Suppressor 93%
- Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies. 92%
Similar papers in this journal
- An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types 92%
- Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer 91%
- Molecular subtyping improves prognostication of Stage 2 colorectal cancer 91%
Similar papers in this journal
- Assessment of the Utility of Gene Positioning Biomarkers in the Stratification of Prostate Cancers 90%
- Deletion of FUNDC2 and CMC4 on chromosome Xq28 is sufficient to cause hypergonadotropic hypogonadism in men 90%
- A tissue specific atlas of gene promoter DNA methylation variability and the clinical value of its assessment 90%
Similar papers in this journal
- Multi-omic signatures identify pan-cancer classes of tumors beyond tissue of origin. 95%
- The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors 93%
- Differential stromal reprogramming in benign and malignant naturally occurring canine mammary tumours identifies disease-promoting stromal components 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.